What Happened

A pharmacy technician at a Twin Falls, Idaho pharmacy was sentenced to 12 months and one day in federal prison for distributing a controlled substance.

The technician stole bottles of oxycodone and hydromorphone from pharmacy stock and sold them to a buyer, arranging the exchanges by text message and leaving the pills in a car glove box in the pharmacy parking lot in exchange for cash. On October 6, 2014, two bottles of 100 oxycodone 20 mg tablets and two bottles of 100 hydromorphone 4 mg tablets were sold; on October 14, 2014, three bottles of 100 oxycodone 30 mg tablets were left in exchange for $1,500.

What the Record Shows

Sentenced to 12 months and one day in prison for distributing a controlled substance, plus three years of supervised release and a $1,000 fine.

Why It Matters for Diversion Programs

This entry comes from a primary source rather than a federal enforcement release, and it is recorded as reported: Stole bottles of controlled-substance prescriptions from pharmacy stock, arranged sales by text message, and left the bottles in a car glove box in the pharmacy parking lot in exchange for cash. Board and news records are a lagging indicator - by the time a licensing authority or a reporter learns of a diversion, the diversion was normally detected internally first, which makes each entry a signal that inventory reconciliation, waste observation or dispensing oversight failed earlier.

Sources

What Went Wrong

A pharmacy technician was able to repeatedly remove full bottles of Schedule II opioids from stock and hand them off in a parking lot without a prescription ever being questioned. Key failures included:

  • Pharmacy stock of Schedule II drugs was accessible to a technician without a second-person check on outbound bottles.
  • No reconciliation caught multiple full 100-count bottles leaving inventory without a corresponding filled prescription.
  • The theft was discovered by law enforcement investigation rather than by the pharmacy's own internal controls.
  • No monitoring flagged a technician's access patterns to Schedule II stock for review.

How It Could Have Been Prevented

  • Require two-person verification whenever full bottles of Schedule II medication are pulled from bulk stock.
  • Reconcile bulk inventory counts against dispensed-prescription records on a frequent, scheduled basis rather than relying on periodic biennial counts.
  • Restrict pharmacy technician access to bulk Schedule II stock to what is needed for immediate, verified prescription fills.
  • Use inventory management software that flags unusual bulk-bottle removals for pharmacist review.
  • Screen and monitor employees with access to controlled substances per DEA guidance (21 C.F.R. §1301.90).